Geron Gets Shareholder Action Over Cancer Drug Trimmed
By Beth Winegarner ( April 10, 2015, 7:02 PM EDT) -- A California federal judge on Friday trimmed a consolidated proposed shareholder class action accusing Geron Corp. of improperly touting the prospects of its cancer drug imetelstat before the U.S. Food and Drug Administration put a hold on the drug's clinical trial over concerns of liver toxicity....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.